Skip to main content

Tophaceous Gout Clinical Trial

Because Every Flare Brings Us Closer to Relief and Improved Mobility

Concerned About Tophaceous Gout?

Explore Clinical Trials That Could Shape Future Treatments

Tophaceous gout is a form of chronic gout characterized by the buildup of urate crystals under the skin, forming nodules called tophi. These deposits can cause joint pain, swelling, stiffness, and reduced mobility. Tophaceous gout is associated with recurrent flares and long-term joint damage if left untreated.

Revive Research Institute is conducting tophaceous gout clinical trials to evaluate potential treatment options. These studies aim to assess the safety and efficacy of therapies designed to reduce urate levels. If you are in Michigan, you may be eligible to participate in a tophaceous gout clinical trial in Michigan.

Are You Eligible to Participate?

To be eligible for our clinical trial for tophaceous gout, individuals must meet the following criteria:

  • Male or female between 18 to 75 years of age
  • Have been diagnosed with gout for at least 1 year

*Additional criteria may apply

Participation in tophaceous gout clinical trials provides access to expert care, study-related medication, and regular health monitoring by experienced medical professionals.

This field is for validation purposes and should be left unchanged.
Who is this information for?*(Required)

Please provide YOUR contact information only.

Name(Required)
Best Time to Call(Required)
User Agreement(Required)
For more info, please visit Privacy Policy.
Tophaceous Gout Clinical Trials Flyer

About the Clinical Trials for Tophaceous Gout

Tophaceous gout results from long-standing hyperuricemia, which leads to monosodium urate crystal deposition in joints and soft tissue. The condition can cause chronic pain, joint deformity, and decreased quality of life.

Revive Research Institute is conducting clinical trials to evaluate investigational potential treatment options designed to lower urate levels and reduce tophi. These studies aim to provide evidence for potential treatments that may improve joint health and overall mobility.

All study-related care, including medical evaluations, lab tests, and investigational medication is provided at no cost, and insurance is not required. Eligible participants may also receive compensation for time and travel.

If you’re interested in learning more, complete the form above, and a member of our research team will contact you to discuss your eligibility. A brief conversation about your health and medical history will help determine if a clinical trial may be right for you.

Get Started: What to Expect?

If you are living with tophaceous gout, you may qualify for a paid clinical trial exploring potential treatment options. After completing the interest form above, a research team member will contact you for a brief pre-screening to review your health history and determine eligibility.

If you appear eligible, you’ll be invited to a screening visit at our clinical research site. During this visit, medical staff will review your history, perform basic exams, and run lab tests to confirm eligibility. Before any procedures begin, you’ll be asked to review and sign an Informed Consent Form (ICF) outlining the study’s purpose, procedures, and potential risks and benefits.

Our team ensures you fully understand your role in the study and what to expect throughout participation. You are encouraged to ask questions at any stage. Your participation helps advance research toward future treatment options for tophaceous gout.

Age

18 to 75 years of age

Condition

Tophaceous Gout

Location

Michigan

Understanding Tophaceous Gout

Tophaceous Gout Clinical Trials

Tophaceous gout is caused by chronic hyperuricemia, which leads to the formation of urate crystals in joints, cartilage, and soft tissue. These crystals provoke inflammation, pain, and joint damage over time.

Causes of Tophaceous Gout

Risks and Symptoms of Tophaceous Gout

  • Formation of visible or palpable tophi in joints and soft tissue
  • Recurrent, painful gout flares
  • Joint stiffness and reduced mobility
  • Risk of chronic joint damage and deformity

Currently, treatments focus on lowering uric acid levels through medication, but not all patients achieve sufficient urate reduction, which is why participation in tophaceous gout clinical trials is essential for developing new therapies.

Frequently Asked Questions (FAQs)

Your Guide to Common Questions

We’ve gathered answers to some of the most common questions about tophaceous gout, its management, and steps you can take to protect joint health.

1. What is tophaceous gout?

A chronic form of gout where urate crystals accumulate under the skin, forming nodules called tophi.

2. What causes tophaceous gout?

Prolonged high uric acid levels in the blood, often influenced by genetics and history of gout attacks.

3. How is tophaceous gout diagnosed?

Diagnosis is confirmed through physical examination, imaging, and blood tests measuring uric acid levels.

4. What are the treatment options for tophaceous gout?

Treatment focuses on lowering uric acid levels with medications. Ongoing clinical trials are evaluating investigational therapies that may more effectively reduce tophi and prevent joint damage.

4. Why should I participate in a clinical trial?

Participation may provide access to investigational treatments, free expert care, and the opportunity to contribute to advancing therapy for tophaceous gout.

Close Menu

Revive Research Institute, Inc.

28270 Franklin Road
Southfield, MI
48034

T: 248-564-1485
E: info@rev-research.com